News

Alexis Ellington has a renewed outlook on life after being the first Saint Luke's patient to receive a new cancer treatment called Bispecific T-cell Engagers therapy, or BiTE.

We are talking about lung cancer and how precision oncology helps patients diagnosed with the disease with treatment.

Lynn vividly remembers how she felt when she found out she had stage 2 breast cancer at age 44, shortly after cancer claimed her sister’s life.